David Fellows
Chairman

David Fellows is the Chairman of our Board of Directors and has more than 25 years of industry experience. Mr. Fellows has been the Chief Executive Officer of Applied Genetic Technologies Corporation (AGTC), a private biopharmaceutical company, since November 2022. Previously, Mr. Fellows served as the Chief Executive Officer and board member of Nightstar Therapeutics plc, a publicly-traded biotechnology company, from January 2015, and as a member of its board of directors from September 2017, until its acquisition by Biogen Inc., a publicly-traded biotechnology company, in July 2019. Before that, he served as the Vice President of Vision Care at Johnson & Johnson, from September 2005 to December 2014. Mr. Fellows serves on the boards of directors of AGTC, Jaguar Gene Therapy and Oxular Ltd. and served on the board of directors of Gyroscope Therapeutics until its acquisition by Novartis in January 2022. Mr. Fellows has also served on the board of the non-profit Glaucoma Foundation since May 2006. Mr. Fellows holds a B.A. in Psychology from Butler University.